Although cardiovascular disease is a leading cause of death for women, they remain underrepresented in clinical trials for common heart conditions. These findings, by investigators in the Smidt Heart Institute at Cedars-Sinai, were presented at the ESC Congress 2025 in Madrid.
Few women participate in studies for common cardiac conditions, according to study
